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ABSTRACT
Accurate duplication of chromosomal DNA is essential for the transmission of genetic information.
The DNA replication fork encounters template lesions, physical barriers, transcriptional machinery,
and topological barriers that challenge the faithful
completion of the replication process. The flexibility of replisomes coupled with tolerance and repair
mechanisms counteract these replication fork obstacles. The cell possesses several universal mechanisms that may be activated in response to various
replication fork impediments, but it has also evolved
ways to counter specific obstacles. In this review, we
will discuss these general and specific strategies to
counteract different forms of replication associated
damage to maintain genomic stability.
INTRODUCTION
The efficient duplication of genetic information demands
the unimpeded progression of the replication fork. DNA lesions and physical barriers pose great threats to the faithful
completion of replication. Thus, the cell has developed overlapping DNA damage repair and tolerance mechanisms to
ensure that these obstructions do not result in genomic instability.
In most cases, lesions are not absolute impediments to
replication fork progression. Replisomes can replicate over
them, switch template strands, switch polymerases (Pols),
reprime, or pause to give more time for repair. Moreover,
replisome components are flexible, where functional uncoupling can occur between helicases and Pols, as well as leading and lagging strand Pols (1,2). Such dynamics built into
the replication machinery represent the earliest tolerance
mechanisms for template damage. However, due to the high
* To

number of challenges to replication, the eventual collapsing
of the fork, defined as losing the capacity to continue DNA
synthesis, is inevitable. This is where multiple DNA repair
pathways are engaged based on the type of damage.
Some of the common types of lesions encountered
by replication forks are ribonucleotides, base lesions, cyclobutene pyrimidine dimers (CPDs), interstrand crosslinks
(ICLs), DNA–protein crosslinks (DPCs), and R-loops.
These impediments represent a serious problem, particularly during replication, due to two reasons. First, although
repair pathways may still remove the damage during replication, their uncontrolled action could be detrimental, since
the DNA in the vicinity of replication fork is single-stranded
DNA (ssDNA). Excising the lesion from ssDNA, as would
be the case in base excision repair (BER), nucleotide excision repair (NER), and ribonucleotide excision repair
(RER), would result in a DNA break and fork collapse. Second, the replication machinery itself potentially transforms
the latent DNA damage into a more deleterious form. For
example, ssDNA breaks are converted to double-stranded
breaks (DSBs) upon encountering the progressing fork (3),
and the collisions of replication machinery with trapped
topoisomerases generates DSBs by ‘replication run-off’ (4).
These replication-associated DSBs are single ended, requiring recombination for their repair.
The dynamics of replication, coupled with lesion skipping, translesion synthesis (TLS), template switching (TS),
and fork reversal are shared strategies to avoid much of the
replication associated DNA damage, ranging from small
base lesion to large DPCs (Figure 1). Although these shared
strategies are enough to counter most replication associated damage, specific types of damage still require further
processing. In this review, we will first describe the general
strategies to deal with established forms of replication associated damage. Then, specific requirements to deal with
genomic ribonucleotides, R-loops, DPCs and ICLs during
replication will be considered in greater detail.

whom correspondence should be addressed. Tel: +1 314 747 5472; Email: nima@wustl.edu


C The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work
is properly cited. For commercial re-use, please contact journals.permissions@oup.com

Downloaded from https://academic.oup.com/nar/article/49/6/3033/6163082 by Washington University in St. Louis user on 24 April 2021

Mechanisms of damage tolerance and repair during
DNA replication

3034 Nucleic Acids Research, 2021, Vol. 49, No. 6

COMMON STRATEGIES TO DEAL WITH REPLICATION BLOCKS
Replisome-intrinsic features
The presence of lesions on leading and lagging strands have
different consequences for replication. In general, damage
in the lagging-strand template is more tolerable due to the
frequently initiated Okazaki fragments that delay the processing of the damage, leaving gaps behind that can be filled
in post-replication (2,5). On the other hand, damage in the
leading strand is more problematic because of its continuous nature of replication. This raises a question of how the
cell coordinates between leading and lagging strand synthesis during repair occurring in one strand. It has been assumed that DNA synthesis on both strands must be coordinated to avoid strand uncoupling and ssDNA accumulation, yet this dogma has been recently challenged. Investigation of Escherichia coli DNA replication has revealed
that polymerases act fully independently, and such coordination is absent (1). Similarly, human DNA polymerases
have also been shown to function independently in vivo. After reducing the rate of lagging strand synthesis, cells sustain
persistent levels of strand uncoupling and ssDNA accumulation without activation of replication checkpoint signal-

ing (6). Therefore, this independent and stochastic behavior
suggests that at any given time the leading strand synthesis
could be slower or faster than the lagging-strand synthesis. Although the mechanisms behind this are not yet clear,
these studies highlight the unexpected flexibility of the replication machinery to tolerate DNA damage.
In addition to leading-lagging polymerase uncoupling,
leading strand lesions cause the replicative CMG (CDC45MCM-GINS) helicase and DNA synthesis to become functionally uncoupled, because CMG can bypass the damage
while the polymerase is paused. This event generates ssDNA as the leading-strand template is exposed (7–9) (Figure 1A and B). During polymerase pausing, DNA unwinding continues but at markedly reduced rate (∼20% of normal), preventing CMG helicase from running far away from
the polymerase and generating excessive ssDNA. This failsafe mechanism is called the ‘dead man’s switch’ (1). Consistently, a recent report has suggested that the act of leading strand polymerization by itself increases template unwinding rate by CMG (10). While the underlying mechanism is unknown, the nascent leading strand may prevent
backtracking of the CMG. This provides an additional failsafe to the ‘dead man’s switch’ to limit excessive uncoupling
that can lead to significant ssDNA accumulation.
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Figure 1. General strategies to bypass and repair DNA damage during replication. (A) A DNA lesion (black triangle) on the leading strand stops replication
fork movement. (B) The DNA damage leads to the functional uncoupling of DNA polymerases and the replicative helicase, since the helicase can bypass
the lesion without association with the polymerase. Several pathways are employed to bypass or repair the damage through (C) lesion skipping, where
repriming occurs downstream the lesion; (D) template switching, where the newly synthesized DNA strand is used as the template; (E) fork reversal, where
the nascent strands reanneal, giving the chance for DNA repair pathways to remove the damage without collapsing the replication fork; (F) or translesion
synthesis, where specialized TLS polymerases temporarily replace the replicative polymerases to bypass the lesion.
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Polymerase repriming, template switching, and fork reversal

Translesion synthesis (TLS)
When replication forks stall, low fidelity TLS Pols transiently replace the replicative Pols to help bypass the lesion
(Figure 1F). Mammalian cells have at least seven enzymes
with TLS activity, including four Y-family Pols (, ,  and
REV1), one B-family Pol ( ), and two A-family Pols ( and
). In general, TLS Pols have larger catalytic pockets that allow them to accommodate templates lesions. Furthermore,
TLS Pols lack 3 -5 proofreading domains (49). Therefore,
TLS Pols confer damage tolerance at the cost of reduced
replication accuracy. Although TLS Pols are inherently error prone, certain TLS Pols can mediate error-free repair of
specific lesions. For example, TLS Pol accurately bypasses
UV-induced CPD lesions (50). Accordingly, mutations in
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After induction of polymerase-stalling damage such as UVinduced thymine dimers, discontinuous DNA synthesis occurs on both the leading and lagging strands in Saccharomyces cerevisiae, suggesting that repriming downstream
of the lesions is a commonly used option during replication (7). The new primer allows DNA synthesis to resume,
leaving behind a ssDNA gap (Figure 1C). Escherichia coli
reinitiates leading strand synthesis downstream of the damage via DnaG-dependent repriming (11,12), while in metazoans, the repriming at the leading strand preferentially uses
a specialized primase called PrimPol (13–16). The mechanisms responsible for activation of repriming are largely unknown, although a recent report has found that cells adapt
to repeated cisplatin exposure by increased expression of
PrimPol under certain conditions (16). PrimPol interacts
directly with RPA, and it is possible that increased RPAcoated DNA, which would signal the presence of markedly
damaged template, is the primary trigger to recruit Primpol
(17,18). An alternative mechanism of avoiding a damaged
DNA template is template switching (TS). This is an errorfree mode of DNA synthesis that allows the stalled replication fork to use the newly synthesized strand as the template
to avoid the lesion. TS activity is regulated by ubiquitination and SUMOylation of PCNA, and involves recombination between the nascent sister strands (19,20). Upon initiation of template switching, a DNA Pol extends the stalled
nascent DNA along the nascent sister strands (Figure 1D).
The paired nascent strands can be resolved by a dissolution
mechanism akin to termination of homologous recombination (21). In budding yeast, it has been demonstrated that
replicative helicase-coupled repriming by Pol␣/Primase facilitates TS. As a result, defects in Pol␣/Primase cause defects in strand annealing and reversed fork formation (22).
Another mechanism to deal with common template obstructions is fork reversal. Fork reversal results in reannealing of the nascent strands without further DNA Pol activity, leading to the formation of a ‘chicken foot’ structure
(Figure 1E). Replication fork reversal (i) allows additional
time for repair, (ii) protects ssDNA at the stalled fork, (iii)
could serve as a mechanism of TS and (iv) avoids the collision of replication machinery with DNA lesions present
ahead of the fork (23). It is estimated that about 15–30%
of the forks are reversed after treatment with various genotoxic agents. This suggests that fork reversal is a global
response to replication stress (24). Fork reversal is mediated by several proteins including ZRANB3, SMARCAL1,
HLTF, FBH1, WRN, RAD54, FANCM, as well as RAD51
(25,26). It is largely unknown if they act in coordination
with each other, or independently in different regions of the
genome, or in different damage contexts. Once a reversed
fork is formed, it creates a DSB that needs to be protected
from nucleases, such as MRE11 and DNA2, which degrade
and collapse the reversed fork. This protection is generally
thought to be RAD51-dependent (27–29).
Besides its role in fork protection, RAD51 promotes
fork reversal (24,29), and mediates the restart of stalled or
collapsed forks (30). Surprisingly, a recent study demonstrated that RAD51 DNA binding activity alone is sufficient for both replication fork reversal and protection, and

only the strand exchange enzymatic activity is required for
replication fork restart (31). These roles of RAD51 at the
fork could be positively or negatively regulated, and many
of the canonical factors involved in Rad51-mediated homologous recombination (HR) are also involved in fork
protection. For example, BRCA2 functions during HR
by displacing the single-stranded DNA-binding protein,
RPA, with RAD51 to promote the strand exchange reaction (32). Moreover, BRCA2 protects stalled replication
forks from extensive nucleolytic degradation through stabilization of the RAD51 filament (28). Besides BRCA1
and BRCA2, which promote RAD51 recruitment, RAD51
paralogs, MMS22L–TONSL, and BOD1L also positively
support RAD51 function in fork protection (33–35). The
BRCA1 antagonist, 53BP1, has also been reported to play a
role in fork protection, although this was not observed consistently between various groups (36–39). Recently, this contradiction was resolved by showing that the role of 53BP1
in fork protection is dependent on the chronic versus acute
inactivation of 53BP1 (40). This suggested that distinct
molecular pathways may exist for fork protection; indeed,
the requirement of fork protection proteins depends on
the pathway used in fork remodeling. Specifically, BRCA2,
FANCD2, and ABRO1 protect forks generated by SMARCAL1, ZRANB3, and HLTF, whereas 53BP1, FANCA,
FANCC, FANCG, BOD1L and VHL protect forks remodeled by FBH1 (40). Other proteins, including RADX,
FBH1 and RAD52 prevent excessive fork reversal by negatively regulating RAD51 activity (41–43). This illustrates
the importance of restricting RAD51 activity at forks, because RAD51 overexpression promotes excessive fork reversal, leading to fork degradation and DSBs (42,44).
In addition to the nucleases that degrade nascent DNA
strands during fork reversal, other structure-specific nucleases may process stressed forks following prolonged stalling
(45). Therefore, the requirement for the fork protection
from nucleases is not limited to fork reversal. For example, cancer cells with microsatellite instability are synthetically lethal with defects in WRN helicase (46,47). Recently,
Nussenzweig and colleagues have revealed that the TA repeats form secondary structures that stall replication forks
and require unwinding by the WRN helicase. In the absence of WRN, the TA-dinucleotide repeats are cleaved by
MUS81 nuclease, leading to double strand breaks, DNA
end resection, RPA exhaustion, and cell death (48).
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Replication fork restart
Dormant origins are licensed origins (i.e. have loaded
MCM helicase) that are not activated during replication.
They serve as an important backup to restore replication
when forks are stalled. The high number of dormant origins in mammalian cells reduces the necessity of replication fork restart (56). Moreover, a reversed fork could just
simply merge with a converging fork. Nevertheless, fork
restart does occur in mammalian cells. This restart could
be achieved by repriming (discussed above), helicases, or
break-induced replication (BIR).
Specific helicases, such as RECQ1, WRN and BLM, have
important roles in reversed fork restart. RECQ1 promotes
fork reversal restart, an activity that is negatively regulated by PARP1 to prevent unscheduled fork reversal restart
to give more time for repair (23). Moreover, WRN and
DNA2 induce the resection of regressed arms, leading to
fork restart (57).
Alternatively, if a fork encounters a ssDNA break or
other type of damaged template that collapses the fork,
BIR, a unique type of HR mechanism, can be employed.
Similar to other HR mechanisms, BIR requires extensive
end processing to generate a 3 ssDNA end that allows

RAD51-ssDNA filament formation. RAD51 invades the
homologous template to generate a displacement loop (Dloop) that allows replisome assembly and DNA synthesis. Unlike HR, which typically involves small regions of
DNA synthesis, BIR engages in extensive DNA replication for many kilobases of DNA until the end of the chromosome (58). There are many differences between canonical replication forks and those established during BIR.
First, unlike canonical replication, BIR involves a single
ended DNA that acts independently, and progresses via a
migrating bubble or D-loop (58). Second, BIR synthesis
is asynchronous; the leading strand is synthesized as ssDNA, then the lagging strand uses the leading strand as the
template (59–61). Third, BIR assembles a modified replisome, where an additional Pol␦ subunit, human POLD3,
is added, and the DNA helicase PIF1 activity is required
(60–62). In yeast, the Srs2 helicase is also required to prevent the formation of toxic structures during the invasion
of leading strand into the DNA template (63). Fourth, compared to canonical DNA replication, BIR is associated with
loss-of-heterozygosity, high mutation rates, and chromosomal rearrangements (58). This mutagenic synthesis is due
at least in part to frequent dissociations of modified Pol␦
from the template (58,64,65), and the reduced efficiency
of mismatch repair during BIR (66). BIR synthesis is either rescued by a replication fork coming from the opposite direction or terminated by MUS81 cleavage of the
recombination intermediate (31,67,68). Although canonical BIR is RAD51-dependent, RAD51-independent BIR
has also been identified. The exact mechanism of RAD51independent BIR is unknown, and the relative contributions of RAD51-dependent and independent BIR to replication restart are currently unclear (58).
The above tolerance and repair strategies can be deployed
to deal with virtually all types of DNA damage during replication. Yet, these are insufficient to maintain genome stability. In the next section, we will discuss the additional requirements to deal with specific types of damage during
replication, which are commonly encountered during normal replication or during the presence of certain genotoxins.
GENOMIC RIBONUCLEOTIDES AND R-LOOPS
Ribonucleotide triphosphates (rNTPs) and deoxyribonucleotides triphosphates (dNTPs) are the precursors for
RNA and DNA, respectively. The extra 2 -OH group in the
ribose makes RNA relatively unstable, because it can potentially mediate nucleophilic attack of the sugar-phosphate
backbone, generating a break. RNA is frequently embedded or annealed to genomic DNA, where it interferes with
replication, inducing DNA damage and genomic instability. Paradoxically, DNA replication is the main source of
genomic ribonucleotides, and ribonucleotide incorporation
is the largest fraction of all endogenous DNA ‘lesions’ (Figure 2).
Ribonucleotide bypass by replicative and TLS polymerases
A major issue with ribonucleotides in DNA is that replicative Pols in yeast and human are inefficient at bypassing
them when they are present in the template strand. More-
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the gene encoding Pol result in a genetic predisposition
to skin cancer (51). Other TLS Pols, such as Pol, Pol,
Pol and Pol make errors while replicating UV-induced lesions (49). Due to the mutagenic potential of Pol, it was
suggested to contribute to skin-cancer development. Surprisingly, Prakash and colleagues have found that Pol plays
a protective role against skin cancer caused by UV. This is
attributed to the role of Pol in promoting replication fork
progression in response to UV, which counteracts the formation of DSBs and genome rearrangements. This suggests
that both error-prone and error-free TLS Pols may act as
effective barriers to genomic instability and tumorigenesis
(52). Similar to the mechanisms described above, PCNA
monoubiquitination appears to be a key component regulating TLS polymerase recruitment (53), yet how the cell
‘chooses’ which TLS Pol is activated at any specific time is
largely unclear.
How lesion skipping, TLS, TS and fork reversal are regulated, and how a replisome activates one mechanism over
another when encountering a particular type of lesion is
still largely unknown. Recent evidence suggests that fork reversal and repriming may be mutually exclusive pathways
(16,54). In support of this, UV damage induces an increase
in RAD51 loading onto chromatin in PrimPol depleted cells
(13), whereas the same type of damage induces excessive
elongation of nascent DNA by PrimPol in RAD51-depleted
cells (55). More recently, HLTF has been shown to activate
replication fork reversal and to prevent alternative tolerance
mechanisms. Interestingly, while the loss of HLTF makes
the cells rely on the PrimPol for unrestrained replication,
defect in the HLTF DNA binding HIRAN domain makes
cells rely on translesion synthesis (54). RAD52 could also
play a role in regulating the switch between fork reversal and
repriming (43) Together, these data strongly suggest an antagonistic interplay between the pathways involved in maintaining replication fork dynamics during damage.
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over, the bypassing capability decreases as the number of
consecutive template ribonucleotides increases. For example, the efficiency decreases from 70% to 35% for Pol␦ and
from 66% to 3% for Polε as the number of ribonucleotides
increases from 1 to 3 (69–71). Similarly, physiological levels of rNTPs inhibit mtDNA synthesis by Pol␥ (72). Therefore, genomic ribonucleotide accumulation induces replication stress, leading to DNA breaks and genomic instability, which has been observed in yeast and human cells (73–
79). The replication stress could also be induced indirectly
by DNA breaks generated by spontaneous hydrolysis or by
TOP1-mediated ribonucleotide cleavage, which will be described below.
TLS and TS are important means of bypassing template ribonucleotides (Figure 2) and are activated in RNase
H1/2 depleted cells (74,76). The TLS polymerase Pol
can bypass ribonucleotide-containing DNA and efficiently
copies DNA templates containing four consecutive ribonu-

cleotides (76). Moreover, oxidized ribonucleotides, like 8oxorG, in DNA could be more problematic for replication,
because they strongly block primer extension by Pol␣. Interestingly, TLS pol can bypasses both undamaged and damaged ribonucleotides (80). These results suggest that TLS
Pols may act as genomic ribonucleotide tolerance mechanisms. On the other hand, TLS Pols can use rNTPs as a
substrate to bypass certain lesions. Pol was reported to bypass abasic sites and 8-oxo-G lesions using rNTPs as substrates (81). Moreover, under limited dNTP pools triggered
by hydroxyurea (HU), robust ribonucleotide incorporation
is mediated by human TLS Pol during TLS of CPD, 8-oxoG, 8-met-G and a cisplatin intrastrand guanine crosslink.
These results suggest that Pol can contribute to the accumulation of genomic ribonucleotides (82,83). In the presence of RNase H, this may be an acceptable compromise.
However, in the absence of RNase H activity, Pol activity
becomes increasingly cytotoxic. Consistently, the deletion
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Figure 2. Genomic ribonucleotide repair and bypass during replication. (A) DNA polymerases incorporate ribonucleotides (blue ‘R’) during replication
which can be bypassed, removed by ribonucleotide excision repair (RER), or processed by topoisomerase I (TOP1). (B) Left unrepaired, a replication fork
would encounter a ribonucleotide in the template strand. The replicative DNA polymerases are inefficient in bypassing template ribonucleotides, leading
to replication stress. In this case, translesion synthesis (TLS) or template switching (TS) are activated to bypass the ribonucleotides to complete replication.
(C) During RER, RNase H2 incises 5 to the embedded ribonucleotide, DNA polymerase ␦ generates a flap which is nucleolytically processed by FEN1,
followed by ligation, leading to error-free repair. (D) In the absence of RER, TOP1 mediates the removal of genomic ribonucleotides. TOP1 incises 3
to the embedded ribonucleotide. Then, nucleophilic attack by the 2 -OH group on the ribose generates a 2 ,3 -cyclic phosphate and releases TOP1. The
2 ,3 -cyclic phosphate can be reversed by TOP1 or removed by a second TOP1 cleavage, or by various nucleases. Alternatively, the trapped TOP1 can be
removed in a manner which may lead to a small deletion, or via TDP1 in an error-free manner.
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of Pol rescues the HU sensitivity of RNase H deficient cells
(84).

potential therapeutic value of PARP1 inhibitors in the treatment of metastatic prostate cancer and chronic lymphocytic
leukemia where RNase H2 is frequently deleted (79).

Ribonucleotide excision repair (RER)
Replication block by R-Loops and its repair mechanisms
During transcription, newly transcribed RNA can hybridize with the transiently accessible template strand
downstream of the transcriptional machinery, forming a
structure called an R-loop. Although R-loops play essential physiological functions, they contribute to genome instability, particularly when replication forks collide with
the transcription machinery. Thus, tight R-loop regulation
must be maintained. Factors that function in the transcription process are essential in preventing excessive R-loops
formation. For example, SRSF1 and THO/TREX complex, which mediate mRNA processing, prevent R-loop formation (99,100). Topoisomerases relax negative supercoils
formed behind the transcriptional bubble to reduce the access of mRNA to template DNA, reducing R-loop accumulation (101). Once formed, different factors act to remove Rloops, including RNase H1 and H2, which degrade the hybridized RNA with DNA, and helicases like DHX9, Aquarius, senataxin, and PIF1 which resolve R-loops by unwinding the RNA component away from the template (102,103).
In addition, several components of canonical DNA repair
pathways, including HR (BRCA1, BRCA2), the Fanconi
anemia pathway, and transcription-coupled NER (XPG
and XPF) are also implicated in R-loop suppression (104–
107).
Transcription and replication necessarily share the same
DNA template. When replication forks encounter the transcription machinery, the resulting transcription-replication
collisions (TRCs) can cause potentially lethal DNA damage and genomic instability. Transcription of human genes
that are larger than 800 kb spans more than one complete
cell cycle, so TRCs are inevitable (108). TRCs can occur in
head-on or co-directional orientation, with the former scenario having more deleterious effect than the latter (109).
Head-on TRCs promote the formation of R-loops that
block replication fork progression (109,110). Importantly,
R-loops, but not normal transcription complexes, induce
DSBs during TRCs (109). How a replication fork blocked
by an R-loop can restart remains elusive. Recent studies
have shown that R-loop induced replication fork stalling is
an active process involving cycle of fork reversal, cleavage
and re-ligation. Mechanistically, after RECQ1 mediates reverse branch migration, RECQ5 disrupts RAD51 filaments
to prevent a new round of fork reversal and to facilitate fork
cleavage by MUS81. RAD52 and LIG4/XRCC4 help to
catalyze fork re-ligation. Interestingly, this cycle allows the
movement of the replication machinery through oppositely
transcribed DNA regions without disrupting transcription
(111). In support of this model, a recent study has shown
that ATR-Chk1 is activated by R-loops through the action
of MUS81 on reversed forks. Activated ATR prevents TRCs
as well as excessive cleavage by MUS81, and enforces cell cycle arrest (112). Taken together, it is likely that R-loops may
function as a signal for potential TRCs to activate the fork
cleavage and re-ligation cycle to resume the transcription of
associated genes.
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RER, which is considered to be error free, is the primary
pathway for the removal of genomic ribonucleotides, and is
mediated by RNase H (Figure 2). The eukaryotic RNase
H family consists of the monomeric RNase H1 and the
trimeric RNase H2 (A, B and C subunits) (85). RNase H1
requires at least a stretch of four consecutive rNMPs to
cleave an RNA-DNA hybrid. While it is not required during
canonical RER, its activity is essential for mtDNA replication and R-loop removal (86,87). On the other hand, RNase
H2 can act both on stretches or single incorporated rNMPs in the genome (87). RNase H2 incises the DNA on
the 5 side of the ribonucleotide. Then, Pol␦ (or, less efficiently Polε) performs strand displacement synthesis, creating a flap that is subsequently removed by FEN1 or EXO1.
The nick is sealed by DNA ligase (87). Mammalian RNase
H2 is recruited to replication forks through the interaction of RNASEH2B and PCNA as well as the catalytic
site of RNASEH2A (88,89). Both yeast and mammalian
cells lacking RNase H2 activate replication stress signaling and have higher genomic instability (73–79). Moreover,
cells lacking RNase H2 accumulate high levels of micronuclei that lead to cGAS-STING-mediated inflammatory signaling (90). Due to the role of ribonucleotides in inducing replication stress, ATR inhibition is synthetically lethal
in RNase H2 deficient cells (91), highlighting one of the
many essential functions of ATR in response to replication
stress.
In the absence of RER, topoisomerase 1 (TOP1) mediates ribonucleotide cleavage, creating mutagenic 2 ,3 -cyclic
phosphate ends (Figure 2). TOP1 cleaves the DNA at the
3 -side of a ribonucleotide, generating a covalent TOP1DNA complex, which is often referred to as the topoisomerase cleavage complex (TOP1cc). Subsequently, the 2 OH of the ribose sugar attacks the phosphotyrosyl linkages
of TOP1cc. The resulting nick flanked by the 2 ,3 -cyclic
phosphate and 5 -OH is not capable of ligation (92,93). Several scenarios have been suggested for the processing of this
nick. First, the reversible re-ligation of the nick by TOP1
allows a second attempt of the excision repair (94,95). Second, TOP1 can initiate a second cut on DNA two base pairs
upstream of the nick, releasing rNMP-dNMP dinucleotide.
In this case, the TOP1cc could be released by TDP1, leaving
behind a gap that can be repaired in an error-free manner
(95). Alternately, TOP1 may re-ligate the DNA backbone,
causing deletions (92,94,95). On the other hand, processing of the 5 -OH via Srs2 helicase and Exo1 nuclease, and
the 2 ,3 -cyclic phosphate by the abasic endonuclease Apn2
creates a gap that inhibits TOP1-mediated ligation, thereby
reducing the risk of mutations (96,97). Third, TOP1 can
cut the DNA strand opposing the rNMP, creating a DSB
(98). Thus, it is clear that TOP1-dependent ribonucleotide
excision is potentially highly mutagenic, leading to gene
deletions and chromosomal rearrangements (78,92,94,98).
Interestingly, in the absence of RNase H2, ribonucleotide
cleavage by TOP1 results in lesions that trap PARP1 by
PARP inhibitors, leading to cell killing. This highlights the
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DNA–PROTEIN CROSSLINKS

DPC repair mechanisms
The diversity of the potential components of a DPC likely
served as the basis for the evolution of multiple mechanisms to deal with these lesions. For example, Topccs may
be flanked by a SSB or a DSB in the case of TOP1cc and
TOP2cc, respectively. Regardless, the collision of replication machinery with TOP-DPCs could lead to DSB formation. In addition to the general repair strategies (Figure 1), TOP-DPCs have dedicated enzymes for their removal, called tyrosyl-DNA phosphodiesterases, or TDPs.
TDP1 and TDP2 hydrolyze the phosphodiester bond between DNA and the tyrosine residue of TOP1 and TOP2,
respectively (Figure 3B). TDP1 activity produces 3 phosphate ends, which require further processing by PNKP, fol-
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Proteins can be covalently and irreversibly linked with
DNA, forming DNA–protein crosslinks (DPCs). DPCs are
highly detrimental to cells because they constitute large
adducts that potently block DNA replication (Figure 3).
Various chemotherapeutics are used in the clinic which
induce DPCs. As mentioned earlier, topoisomerases form
covalently-bound TOPccs as part of their catalytic cycle.
Topoisomerase poisons such as irinotecan and etoposide
selectively trap TOP1 and TOP2, respectively, on DNA by
stabilizing the TOPcc (113,114). Moreover, pyridostatin, a
compound that stabilizes G-quadruplex (G4) sequences has
been recently shown to induce TOP2cc formation (115).
Similarly, 5-aza-dC is a cytosine analogue that is incorporated in DNA and acts as a pseudosubstrate for DNA
methyltransferase 1 (DNMT1), resulting in its covalent
trapping (116). Platinum derivatives, such as cisplatin, induce nonspecific crosslinking of chromatin-interacting proteins to DNA (117), and PARP inhibitors, such as Olaparib,
induce PARP trapping on DNA. Although not crosslinked
covalently, PARP is tightly bound to DNA, resulting in a
DPC-like lesion (118). Exogenous sources, like ionizing radiation (IR) and UV, can also cause DPCs (119). Finally,
abasic sites, which can occur spontaneously or during base
excision repair, have intrinsic protein-crosslinking properties, leading to covalent trapping of histones and the newly
discovered HMCES protein (120).
Due to the large size of DPCs, it was initially thought that
they block both replicative Pols and CMG helicase. Surprisingly, recent reports revealed that DPCs do not block
CMG, and moreover DPC repair does not require CMG
unloading (discussed below). A lagging strand DPC can
be immediately bypassed by CMG, perhaps with the help
of the accessory protein MCM10, to ensure lagging strand
DPCs do not interfere with CMG movement (121). Unexpectedly, Walter and colleagues have shown that CMG
can also bypass an intact leading strand DPC before proteolysis. The DNA helicase RTEL1 facilitates the bypass by
generating ssDNA beyond the DPC. This allows the CMG
to bypass the DPC, which then triggers DPC proteolysis
(9,122). CMG slows after bypass, likely due to uncoupling
from DNA synthesis as previously mentioned (1,9). This
further reinforces the remarkable capacity of CMG to overcome obstacles, and the flexibility of the replisome.

lowed by the canonical SSB repair to seal the nick. On
the other hand, TDP2 produces a clean DSB which is directly processed by non-homologous end joining (NHEJ)
(123). TDP1 and TDP2 are incapable of removing the intact TOP1cc and TOP2cc and require their pre-proteolysis
(see below) (124,125). A recent report has discovered that
TEX264–p97 complex facilitates the proteolysis of TOP1cc
via SPRTN upstream of TDP1 during DNA replication
(126). Interestingly, the SUMO ligase ZATT (ZNF451) may
mediate direct resolution of the TOP2cc by TDP2 without
the need for TOP2cc pre-proteolysis (127). Thus, the cell has
evolved multiple possible mechanisms to deal with just one
particular group of DPCs.
Beyond these specific mechanisms, the MRN complex (Mre11–Rad50–NBS1) is a highly conserved nuclease
which may function to remove DPCs (Figure 3B). MRN is
unaffected by the identity of the protein adduct and both
the enzymatic and non-enzymatic DPCs are potential targets for MRN (128–131). Moreover, MRN can remove protein adducts at the 5 end or the 3 end of DSBs. Such endonucleolytic activity produces a clean DSB, which can be
repaired by canonical DSB repair mechanisms (130). The
CtIP nuclease (Sae2 in S. cerevisiae), stimulates the endonucleolytic cleavage of DPCs by MRN (130,132). Additional
nucleolytic activities are likely involved in excising TOP1ccs.
The proteasome participates in DPC removal (Figure 3),
and proteasome inhibitors impair DPCs removal and sensitize cells to DPC inducing agents (125). The proteasome
degradation requires DPC polyubiquitylation, which is partially dependent on the E3 ligase TRAIP (122). In recent
years, a more specific proteolytic pathway has been identified with the finding of Wss1 in yeast cells and its orthologs
SPRTN in mammalian cells (133). Wss1/SPRTN can cleave
almost every type of DPC, including TOPcc, high mobility
group protein 1, histones, and itself in a DNA-dependent
manner (133–138). SPRTN can also degrade nonubiquitylated DPCs (122). Spartan is recruited by binding ubiquitinated PCNA via its UBZ domain and a PIP box (139,140).
As expected, the protease activity of SPRTN is tightly regulated via its DNA binding, ubiquitination and autocleavage
(133–138).
Even after DPCs proteolysis by Wss1/SPRTN or the proteasome, they are not fully removed from DNA. Small peptides are left covalently bound to DNA, which in turn can
block replicative Pols. The peptide-DNA can be processed
by TDPs in case of TOPcc (126). In case of non-enzymatic
DPCs, the small peptides that remain can be removed by
NER (Figure 3C), which is only capable of excising DPCs
up to a certain size (8–10 kDa) (141,142). However, it seems
that the action of NER is limited to G1 phase prior to replication (133). In addition, bypass of peptide-DNA may rely
on the TLS pathway (143). Finally, if a DPC is left unprocessed, the permanently stalled replication fork might be
cleaved by endonucleases, resulting in a single-ended DSB.
This situation may therefore trigger break-induced replication (133). More recently, genetic screening using tdp1/wss1
double-mutant yeast has identified the aspartate protease
Ddi1 to act as alternative to Wss1 and 26S proteasome to
resolve DPCs (144). Thus, the cell has evolved multiple complex mechanisms by which DPCs can be processed, highlighting the importance of dealing with this type of lesion.
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While it is widely accepted that DPCs challenge the integrity of the genome during replication, Cortez et al. recently suggested a role for DPCs during faithful replication. An evolutionarily ancient protein called HMCES was
found to be a sensor of abasic sites in ssDNA during replication (120). Strikingly, it generates a DPC with the ring open
form of the abasic site deoxyribose to shield these lesions
from error-prone processing by AP endonucleases and TLS
Pols. How the HMCES-DNA is eventually resolved is unknown. In contrast to the above model, a recent study has
shown that AP endonucleases may act in concert with HMCES for the resolution of AP sites. This study suggested that
the HMCES-DPC may help to recruit AP endonuclease to
channel these lesions to the proper repair pathway (145). In

support of this, AP sites are known to react with several proteins such as histones, KU heterodimer, human ribosomal
protein S3, nucleoside diphosphate kinase, PARP1, and several others (146–152). It is possible that HMCES may function in these two distinct manners in a cell-cycle dependent
fashion; that is, it may promote AP endonuclease function
outside of S-phase yet protect from the deleterious effects
of AP endonuclease during replication, which could potentially induce a DSB. Certainly, further studies are needed to
clarify the role of the HMCES-DPC and its regulation.
Several critical questions regarding the repair of DPCs
during replication remain. Specifically, why the cell has invested in several distinct proteases that perform the same
or similar function in DPC removal is unknown. The fact
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Figure 3. DNA–protein crosslink (DPC) repair and bypass during replication. (A) A DPC blocks replication fork progression. The repair of the DPC
begins with proteolysis of the DPC by various proteases. (B) The repair of topoisomerase induced DPCs is a special case, because TOP-DPCs are flanked
by a single strand break (SSB) or double strand break (DSB), in case of topoisomerase I and II, respectively. The collision of the replication fork with
trapped topoisomerases will eventually lead to a DSB by ‘replication run-off’. For simplicity, only the collision of replication fork with topoisomerase
I-induced DPC is depicted here. After proteolysis, the peptide-DNA crosslink can be removed by TDP1 or nucleases. The resulting DSB is repaired by
homologous recombination (HR) to induce fork restart and progression. Although not depicted here, the replication fork can avoid the collision with
trapped topoisomerases and the generation of DSB by inducing fork reversal ahead of the DPC. (C) For all forms of DPCs, the remaining peptide–DNA
crosslink can be bypassed by translesion synthesis (TLS), and subsequently removed by nucleotide excision repair.
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that removal of each of these factors has some independent
phenotype suggests that their functions are not completely
overlapping. Moreover, the discovery of HMCES suggests
that cells may have adapted to utilizing physiological DPCs
potentially for modulating repair pathway choice.
INTERSTRAND CROSSLINKS

Replication block by interstrand crosslinks and their repair
mechanisms
ICLs that occur outside of S-phase are believed to be repaired by the NER pathway (158). However, in S-phase,
ICL repair starts with the formation of an X shaped DNA
structure that occurs upon convergence of two replication
forks at the ICL site (159,160) (Figure 4A). Unhooking the
crosslink is essential for the completion of DNA synthesis.
This is achieved through incision-dependent or incision independent pathways. TRAIP (E3 ubiquitin ligase) acts as
a switch between these different repair pathways by controlling CMG ubiquitination. Short ubiquitin chains recruit
NEIL3 glycosylase, while excessive ubiquitination activates
the Fanconi anemia (FA) pathway (161). In turn, this ubiquitination regulates the downstream mode of ICL repair.
Higher levels of TRAIP-mediated ubiquitination promotes CMG unloading at the ICL by the AAA+ ATPase p97, which functions as an essential step to initiate the Fanconi anemia (FA) pathway (161) (Figure 4B).
The FA pathway involves an intricate process that is abrogated in a genetic disease characterized by congenital
abnormalities, bone marrow failure, and cancer predisposition. To date, 22 FA genes have been identified, which
are grouped into FA core complex (encoding an E3 ligase complex), the FANCI/FANCD2 (ID) complex, and
the downstream effector proteins. When DNA replication
is blocked by ICL, the FA core complex (FANCA, B, C,
E, F, G, L and M) monoubiquitinates the ID complex
(157). Monoubiquitinated ID complex constitutes an essential gateway for ICL repair by recruiting downstream
factors to initiate excision, TLS and HR. The mechanism by which the ID complex is targeted to ICL is
not clear, but it has been suggested that the recruitment
to a stalled fork precedes the monoubiquitination event
(162). In support of this, a recent cryo-EM study has revealed that monoubiquitination of the ID complex causes
a loss of preference for the ICL lesion and remodels the
complex to become a sliding DNA clamp that functions
to coordinate the downstream repair reaction (163). Removal of the ICL starts with nucleolytic incisions of the
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Unlike the lesions described above, ICLs are toxic lesions that block DNA replication by physically preventing DNA strand separation (Figure 4). Chemotherapeutic agents such as mitomycin C and platinum compounds
(e.g. cisplatin and carboplatin) induce ICLs. Metabolic processes such as histone demethylation, lipid peroxidation,
and alcohol metabolism produce aldehydes which can also
induce ICLs (153–157). These physiological sources of ICLs
likely explain the various mechanisms that have evolved to
repair these lesions.

ICL. SLX4/FANCP and its associated 3 -flap structurespecific endonuclease XPF(FANCQ)/ERCC1, generate nucleolytic incisions and unhook the ICL (164,165). Other
nucleases, MUS81/EME1 and FAN1, have been also implicated in ICL incision (157,166). Following unhooking,
the ICL remnant is bypassed by TLS polymerases REV1
and Pol , a heterodimeric complex of REV3 and REV7
(167). The other DNA duplex with a DSB will be repaired by canonical HR, using the restored nascent strand
as a template for strand invasion. FA pathway deficiency
not only causes reduction in HR efficiency, but also increases deleterious repair through NHEJ, which induces genomic instability. Accordingly, ICL sensitivity can be rescued by inhibition of specific NHEJ factors (168–170).
Lastly, FANCD2 is deubiquitinated by USP1–UAF1 complex to terminate the FA pathway (171,172). Interestingly,
D’Andrea and colleagues have recently identified TRIP13
ATPase as a negative regulator of REV7, which links REV1
and REV3 Pol complex. This work suggests that TRIP13
has a role in disassembling the REV7–REV3 TLS complex, serving to regulate another component of the FA
pathway (173). Since TLS has other functions outside of
the Fanconi pathway, it’s likely that these negative regulators evolved separately, yet function in a cooperative
manner to shut off the pathway in the context of ICL
repair.
Unlike FA activation, shorter TRAIP-mediated ubiquitination events on CMG recruits NEIL3 (Figure 4C), a DNA
glycosylase that has functions outside of BER (161). NEIL3
specifically unhooks psoralen-ICL and AP-ICL (formed by
abasic site and an adenosine) during DNA replication in
Xenopus egg extracts. Other forms of ICLs are generally not
substrates for NEIL3. Unhooking ICLs by NEIL3 does not
nick the DNA backbone, and accordingly does not generate DSBs (174). The same result has been confirmed in
human cells, where NEIL3 is also the major pathway for
psoralen-ICLs repair. Interestingly, NEIL3 recruitment to
a psoralen-ICL is strictly PARP-dependent (175). NEIL3
generates an abasic site which in turn is bypassed by TLS
Pols (174). Thus, the NEIL3 pathway is potentially mutagenic but does not require complex processing of a DSB,
which may serve to protect the genome.
Recent work on the repair mechanism of acetaldehyde
(AA) ICLs have suggested that an alternative pathway
may exist for these lesions. Consistent with previous animal models and genetic studies, work in Xenopus egg extracts have discovered that AA-ICL repair requires an active FA pathway (153–156). Unexpectedly, however, about
half of the acetaldehyde-induced ICLs are repaired by a
second, faster mechanism (Figure 4D). This second mechanism is independent of the FA pathway, or any glycosylases, including NEIL3. Moreover, in this rapid route, abasic sites are not generated, nor are any cuts made to the
DNA strands. Instead, the ICL is cut within the crosslink,
leaving the adduct on one of the DNA strands that is bypassed by TLS polymerases REV1 and Pol (155). The unhooking of the AA-ICL by the new mechanism was suggested to be mediated non-enzymatically by the mechanical
force of fork conversion or enzymatically by an unknown
protein.
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Taken together, these relatively recent results suggest that
while the FA pathway can remove virtually all forms of
ICLs, the induced DSB by this mechanism is a potential
source of genomic instability. This may explain the development of other repair pathways for specific types of ICLs,
such as NEIL3, which limit the use of the FA pathway. The
choice between FA activation and NEIL3 mediated bypass
through the degree of CMG ubiquitination by TRAIP permits a stalled replisome to use the latter pathway first; yet
upon its failure, the FA pathway can be activated in its place,
making the DSB as a mechanism of last resort for ICL repair.

CONCLUSIONS AND OUTLOOK
The various tolerance and repair pathways help to guarantee the completion of the replication process. While many of
the molecular mechanisms of these individual pathways are
well understood, their coordinate regulation remains obscure and represents a major gap in our knowledge. For example, how an individual replisome preferentially selects a
specific pathway upon encountering a specific type of damage, whether general or lesion-specific, is not clear. Reminiscent of DSB pathway choice, which involves a commitment to HR or NHEJ, many of these replication-associated
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Figure 4. Interstrand crosslink (ICL) repair during replication. (A) The mechanism of ICLs repair depends on the type of ICL. While the Fanconi anemia
(FA) pathway is the general mechanism to repair most forms of ICLs during replication, other repair mechanisms have evolved to repair specific types
of ICLs. All ICL repair mechanisms require the conversion of replication forks. The E3 ligase, TRAIP, functions to regulate different repair pathways by
controlling CMG ubiquitination. (B) Extensive ubiquitination of CMG by TRAIP lead to the CMG unloading, which is an essential step to activate the FA
pathway. FA pathway regulates the incision of ICLs by nucleases, then activates translesion synthesis (TLS) to bypass the adduct, which is subsequently
removed by nucleotide excision repair. The double strand break (DSB) at one strand is repaired by homologous recombination (HR), using the other
strand as the template. (C) In the case of abasic (AP)-ICL and psoralen-ICL, TRAIP adds short ubiquitin chains on CMG that channels the damage to
NEIL3, which incises the ICL without inducing a DSB. TLS bypasses the adduct and the AP site. (D) In case of acetaldehyde-ICL (AA-ICL), another
mechanism has been recently identified that acts to bypass this lesion. The role of TRAIP or specific enzymes that incise this type of ICL is unknown. This
repair pathway does not induce DSB or an AP site intermediate. All ICL repair converges through TLS bypass of the adduct to complete the repair in an
error-prone manner.
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pathways of repair are antagonistic. Similar to DSB pathway regulation, it is likely that post-translational modifications are in play which function to favor one pathway
over another. Yet, beyond PCNA monoubiquitination versus polyubiquitination, or TRAIP-mediated ubiquitination
of CMG, how the cell selects one particular pathway over
another is far from clear. Second, it is not clear why the cell
developed multiple pathways to fix the same or very similar types of damage during replication. The extreme case is
the presence of largely redundant DPC proteases. It is possible that different types of DPCs require their presence, or
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